Table 1:
Characteristics of the Included Study
Author, Year | Study Design and Methods | Participants | Intervention | Comparator | Outcomes |
---|---|---|---|---|---|
Koek et al, 200928 | Pragmatic, multicentre, single-blinded randomized controlled noninferiority trial | 196 people, aged ≥ 18 years, with psoriasis who were clinically eligible for NB-UVB phototherapy | Home NB-UVB using the TL01 home NB-UVB phototherapy unit (manufactured by Philips) | Outpatient-based standard NB-UVB phototherapy | Primary outcomes: SAPASI 50, PASI 50 Secondary outcomes: SAPASI 75, PASI 75, SAPASI 90, PASI 90 Quality of life: PDI, SF-36 Side effects: mild erythema, severe erythema, burning sensation, blistering |
Abbreviations: NB-UVB, narrowband ultraviolet B; PASI, Psoriasis Area and Severity Index; PDI, Psoriasis Disability Index; SAPASI, Self-Administered Psoriasis Area and Severity Index; SF-36, 36-Item Short-Form Survey.